ACU · Acme United Corp
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACU
this stock
Acme United Corp
|
$243.37M | +57.5% | +1.1% | 26.7 | 2.0% |
|
PG
PROCTER & GAMBLE Co
|
$373.21B | +12.4% | +3.3% | 24.3 | 1.1% |
|
UL
Unilever PLC
|
$142.63B | +1.3% | — | — | 0.2% |
|
CL
Colgate Palmolive Co
|
$74.97B | +19.0% | +1.7% | 37.2 | 3.0% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$47.14B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACU | +3.2% | +1.2% | +55.4% | +0.1% | +57.5% |
| SPY | -0.4% | -1.5% | +5.8% | -0.4% | +11.5% |
| vs SPY | +3.6% | +2.6% | +49.6% | +0.4% | +46.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.